Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
07/2003
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470055A1 Methods for wet granulating azithromycin
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322760A2 G-protein coupled receptors
07/02/2003EP1322656A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
07/02/2003EP1322638A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322612A1 Substituted amino-aza-cycloalkanes useful against malaria
07/02/2003EP1322608A1 Delta1-pyrrolines used as pesticides
07/02/2003EP1322317A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
07/02/2003EP1322291A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
07/02/2003EP1322290A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight
07/02/2003EP1322287A2 Microparticles for delivery of the heterologous nucleic acids
07/02/2003CN1427889A Hybrid cells obtainable from antigen presenting cells
07/02/2003CN1427844A Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents
07/02/2003CN1426811A Action of litsea citrate oil in killing parasite on human body and animal
07/01/2003US6586452 C1 to C4 side chain modified nodulisporic acid analogs
07/01/2003US6586409 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
07/01/2003US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone
06/2003
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051858A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic
06/26/2003WO2003051400A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003WO2003051335A1 Radioopaque sustained release pharmaceutical system
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051304A2 Bioadhesive drug delivery system with enhanced gastric retention
06/26/2003WO2003051294A2 Mitocidal compositions and methods
06/26/2003WO2003051289A2 Solubilized topoisomerase poison agents
06/26/2003US20030120069 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119783 Aqueous compositions containing metronidazole
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030118678 Plant extracts as antiproliferative, viricides and antiparasitic agents
06/26/2003CA2471589A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003CA2470582A1 Mitocidal compositions and methods
06/26/2003CA2469205A1 Bioadhesive drug delivery system with enhanced gastric retention
06/26/2003CA2468986A1 Radioopaque sustained release pharmaceutical system
06/26/2003CA2467279A1 Solubilized topoisomerase poison agents
06/26/2003CA2466010A1 Method of obtaining 2-(2-nitrovinyl)-furan and the use thereof as a coccidiostatic
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320380A2 Tubulin based vaccine against trypanosomiasis
06/25/2003EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/25/2003EP1250343B1 Azalide antibiotic compositions
06/25/2003EP1221845B1 Active ingredient combinations having insecticidal and acaricidal properties
06/25/2003CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
06/25/2003CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof
06/25/2003CN1426311A Medicament for stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and method for production thereof
06/25/2003CN1426309A Adjuvanted genetic vaccines
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583274 Crystalline forms of macrolide antibiotic
06/24/2003US6583265 Cyclosporins
06/24/2003US6582949 Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof
06/24/2003CA2272014C N-aryl/heteroaryl-substituted heterocycles
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050104A1 Novel substance fki-1083 and process for producing the same
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114393 Use of steroidal alkaloids to reverse multidrug resistance
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP1318810A1 Manzamines for treatment of drug resistant infection
06/18/2003EP1318800A1 1-amino-alkylcyclohexanes as trypanocidal agents
06/18/2003EP1318795A2 Anthelmintics for preventing parasitic infections in humans and animals
06/18/2003EP1168920B1 (s)-enantiomer enriched fipronil composition
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1111535C 42,52,82,8š�-tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridine-6,8 [7H]-dione derivatives for use in controlling endoparasites and method
06/17/2003US6579869 Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents
06/17/2003US6579524 Polypeptide having amino acid sequence of C-terminal part of circumsporozoite protein of Plasmodium; oxidized cysteine residue pairs
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048373A1 Novel substance fki-0550 and process for producing the same
06/12/2003WO2003048371A2 Dna vaccine
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048168A2 Trioxane derivatives as antimalaria or anticancer compounds
06/12/2003WO2003048167A1 Trioxane derivatives
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 218